A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Clinical trial NCT06521554 · RECRUITING

Trial details

NCT number: NCT06521554
Sponsor: Nuvalent Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2024-07-18
Primary completion: 2027-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.